甲基化
化学
DNA甲基化
癌症研究
细胞生物学
生物
基因
基因表达
生物化学
作者
Yangyang Pang,Qingwen Meng,Qingyun Guo,Yiqian Xu,Xingyue Fang,Jie Qu,Wen‐Hsiung Li,Lingyu Ran,Kun Chen,Qibing Liu
标识
DOI:10.1615/critreveukaryotgeneexpr.2025059014
摘要
Lysine demethylase 5A (KDM5A) is involved in the progression of various heart diseases. This study aimed to investigate the role of KDM5A in atherosclerosis (AS). Oxidized low-density lipoprotein (OX-LDL) was used to establish AS model in vitro. Gene expression was reverse transcription-quantitative PCR and Western blot. Cytokine release was detected using enzyme-linked immunosorbent assay. Cytotoxicity in EA.hy926 cells was detected using Lactate dehydrogenase assay. Cell viability of EA.hy926 cells was detected using cell counting kit-8 assay. Cell death was detected using terminal deoxynucleotidyl transferase dUTP nick-end labeling assay. KDM5A was highly expressed in ox-LDL-treated EA.hy926 cells. KDM5A knockdown promoted cell viability and suppressed the PANoptosis of EA.hy926 cells induced by ox-LDL. KDM5A bound directly to adhesion G protein-coupled receptor A2 (GPR124) promoter region and transcriptionally suppressed the expression of GPR124 via demethylation H3K4. However, GPR124 knockdown inhibited the cell viability of EA.hy926 cells and promoted PANoptosis. In summary, KDM5A-mediated PANoptosis in AS via downregulating GPR124. This epigenetic alteration-induced PANoptosis lays a theoretical foundation for treating AS.
科研通智能强力驱动
Strongly Powered by AbleSci AI